| P2093 | author name string | Roopa S Pai | |
| | Sanaul Mustafa | |
| | V Kusum Devi | |
| P2860 | cites work | A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. | Q31121891 |
| | Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems | Q33223515 |
| | Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres | Q33267927 |
| | The effect of physical barriers and properties on the oral absorption of particulates. | Q33933337 |
| | Development and validation of liquid chromatography-mass spectrometric method for simultaneous determination of moxifloxacin and ketorolac in rat plasma: application to pharmacokinetic study | Q34159002 |
| | BDDCS applied to over 900 drugs | Q34206152 |
| | Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis | Q34340538 |
| | Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 |
| | Polysaccharide-decorated nanoparticles | Q35857087 |
| | Drug resistance in tuberculosis | Q36026282 |
| | Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | Q36319725 |
| | Nanocarrier-based interventions for the management of MDR/XDR-TB. | Q38375982 |
| | Development of Clotrimazole Multiple W/O/W Emulsions as Vehicles for Drug Delivery: Effects of Additives on Emulsion Stability. | Q39812543 |
| | Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery | Q40188447 |
| | Chitosan and its use as a pharmaceutical excipient | Q40841463 |
| | Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). | Q40862339 |
| | Formulation and optimization of nonionic surfactants emulsified nimesulide-loaded PLGA-based nanoparticles by design of experiments. | Q41904451 |
| | Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report | Q42549700 |
| | Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers | Q42876909 |
| | Moxifloxacin-induced acute liver injury | Q44074843 |
| | Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan | Q44955434 |
| | Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration. | Q46205274 |
| | Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo | Q47297862 |
| | Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles | Q48262899 |
| | PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. | Q51475804 |
| | In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers | Q58622686 |
| | PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution | Q61787443 |
| | Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis | Q62654863 |
| | Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles | Q73990827 |
| | Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process | Q79868027 |
| | Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma | Q80062582 |
| | Preparation and physical characterization of a novel marine oil emulsion as a potential new formulation vehicle for lipid soluble drugs | Q80092625 |
| | Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol with enhanced bioavailability potential | Q87503608 |
| | Analysis of the interferences in quantitation of a site-specifically PEGylated exendin-4 analog by the Bradford method | Q88128085 |
| P433 | issue | 1 | |
| P304 | page(s) | 27-36 | |
| P577 | publication date | 2016-08-30 | |
| P1433 | published in | Drug delivery and translational research | Q27723621 |
| P1476 | title | Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. | |
| P478 | volume | 7 | |